121 related articles for article (PubMed ID: 19277236)
41. Hyaluronic Acid-PEG-Based Diels-Alder
Ilochonwu BC; Mihajlovic M; Maas-Bakker RF; Rousou C; Tang M; Chen M; Hennink WE; Vermonden T
Biomacromolecules; 2022 Jul; 23(7):2914-2929. PubMed ID: 35735135
[TBL] [Abstract][Full Text] [Related]
42. Sustained delivery of anti-VEGF from injectable hydrogel systems provides a prolonged decrease of endothelial cell proliferation and angiogenesis
Fletcher NA; Krebs MD
RSC Adv; 2018 Feb; 8(16):8999-9005. PubMed ID: 35539877
[TBL] [Abstract][Full Text] [Related]
43. Targeting Ocular Drug Delivery: An Examination of Local Anatomy and Current Approaches.
Dosmar E; Walsh J; Doyel M; Bussett K; Oladipupo A; Amer S; Goebel K
Bioengineering (Basel); 2022 Jan; 9(1):. PubMed ID: 35049750
[TBL] [Abstract][Full Text] [Related]
44. Advanced biomedical hydrogels: molecular architecture and its impact on medical applications.
Peters JT; Wechsler ME; Peppas NA
Regen Biomater; 2021 Dec; 8(6):rbab060. PubMed ID: 34925879
[TBL] [Abstract][Full Text] [Related]
45. Hydrogels Classification According to the Physical or Chemical Interactions and as Stimuli-Sensitive Materials.
Bustamante-Torres M; Romero-Fierro D; Arcentales-Vera B; Palomino K; Magaña H; Bucio E
Gels; 2021 Oct; 7(4):. PubMed ID: 34842654
[TBL] [Abstract][Full Text] [Related]
46. Compartmental and COMSOL Multiphysics 3D Modeling of Drug Diffusion to the Vitreous Following the Administration of a Sustained-Release Drug Delivery System.
Dosmar E; Vuotto G; Su X; Roberts E; Lannoy A; Bailey GJ; Mieler WF; Kang-Mieler JJ
Pharmaceutics; 2021 Nov; 13(11):. PubMed ID: 34834276
[TBL] [Abstract][Full Text] [Related]
47. Emerging Role of Hydrogels in Drug Delivery Systems, Tissue Engineering and Wound Management.
Jacob S; Nair AB; Shah J; Sreeharsha N; Gupta S; Shinu P
Pharmaceutics; 2021 Mar; 13(3):. PubMed ID: 33800402
[TBL] [Abstract][Full Text] [Related]
48. Biotechnology and Biomaterial-Based Therapeutic Strategies for Age-Related Macular Degeneration. Part I: Biomaterials-Based Drug Delivery Devices.
Jemni-Damer N; Guedan-Duran A; Fuentes-Andion M; Serrano-Bengoechea N; Alfageme-Lopez N; Armada-Maresca F; Guinea GV; Pérez-Rigueiro J; Rojo F; Gonzalez-Nieto D; Kaplan DL; Panetsos F
Front Bioeng Biotechnol; 2020; 8():549089. PubMed ID: 33224926
[TBL] [Abstract][Full Text] [Related]
49. Engineering Smart Targeting Nanovesicles and Their Combination with Hydrogels for Controlled Drug Delivery.
Elkhoury K; Koçak P; Kang A; Arab-Tehrany E; Ellis Ward J; Shin SR
Pharmaceutics; 2020 Sep; 12(9):. PubMed ID: 32906833
[TBL] [Abstract][Full Text] [Related]
50. Thermoresponsive sol-gel improves ocular bioavailability of Dipivefrin hydrochloride and potentially reduces the elevated intraocular pressure
Alkholief M; Kalam MA; Almomen A; Alshememry A; Alshamsan A
Saudi Pharm J; 2020 Aug; 28(8):1019-1029. PubMed ID: 32792847
[TBL] [Abstract][Full Text] [Related]
51. Safety and Biocompatibility of Aflibercept-Loaded Microsphere Thermo-Responsive Hydrogel Drug Delivery System in a Nonhuman Primate Model.
Kim S; Kang-Mieler JJ; Liu W; Wang Z; Yiu G; Teixeira LBC; Mieler WF; Thomasy SM
Transl Vis Sci Technol; 2020 Feb; 9(3):30. PubMed ID: 32742760
[TBL] [Abstract][Full Text] [Related]
52. Regulation of the Ocular Cell/Tissue Response by Implantable Biomaterials and Drug Delivery Systems.
Baino F; Kargozar S
Bioengineering (Basel); 2020 Jun; 7(3):. PubMed ID: 32629806
[TBL] [Abstract][Full Text] [Related]
53. Hydrogel Biomaterials for Application in Ocular Drug Delivery.
Lynch CR; Kondiah PPD; Choonara YE; du Toit LC; Ally N; Pillay V
Front Bioeng Biotechnol; 2020; 8():228. PubMed ID: 32266248
[TBL] [Abstract][Full Text] [Related]
54. Use of biomaterials for sustained delivery of anti-VEGF to treat retinal diseases.
Seah I; Zhao X; Lin Q; Liu Z; Su SZZ; Yuen YS; Hunziker W; Lingam G; Loh XJ; Su X
Eye (Lond); 2020 Aug; 34(8):1341-1356. PubMed ID: 32001821
[TBL] [Abstract][Full Text] [Related]
55. Review of Stimuli-Responsive Polymers in Drug Delivery and Textile Application.
Chatterjee S; Chi-Leung Hui P
Molecules; 2019 Jul; 24(14):. PubMed ID: 31336916
[TBL] [Abstract][Full Text] [Related]
56. Controlled Release of Vancomycin From a Thermoresponsive Hydrogel System for the Prophylactic Treatment of Postoperative Acute Endophthalmitis.
Dosmar E; Liu W; Patel G; Rogozinski A; Mieler WF; Kang-Mieler JJ
Transl Vis Sci Technol; 2019 May; 8(3):53. PubMed ID: 31293808
[TBL] [Abstract][Full Text] [Related]
57. Ocular Drug Delivery: A Special Focus on the Thermosensitive Approach.
Sapino S; Chirio D; Peira E; Abellán Rubio E; Brunella V; Jadhav SA; Chindamo G; Gallarate M
Nanomaterials (Basel); 2019 Jun; 9(6):. PubMed ID: 31207951
[TBL] [Abstract][Full Text] [Related]
58. Hydrogel-based ocular drug delivery systems: Emerging fabrication strategies, applications, and bench-to-bedside manufacturing considerations.
Cooper RC; Yang H
J Control Release; 2019 Jul; 306():29-39. PubMed ID: 31128143
[TBL] [Abstract][Full Text] [Related]
59. Thermoresponsive Hydrogels and Their Biomedical Applications: Special Insight into Their Applications in Textile Based Transdermal Therapy.
Chatterjee S; Hui PC; Kan CW
Polymers (Basel); 2018 Apr; 10(5):. PubMed ID: 30966514
[TBL] [Abstract][Full Text] [Related]
60. In Situ Cross-linking Hydrogel as a Vehicle for Retinal Progenitor Cell Transplantation.
Park J; Baranov P; Aydin A; Abdelgawad H; Singh D; Niu W; Kurisawa M; Spector M; Young MJ
Cell Transplant; 2019 May; 28(5):596-606. PubMed ID: 30917696
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
